Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 4 | BMC Immunology

Fig. 4

From: Low-dose interleukin-2 can improve salivary secretion but not lymphocyte infiltration of salivary glands in a murine model of Sjögren’s syndrome

Fig. 4

Low-dose IL-2 failed to alleviate immunopathological damage of the submandibular gland in Sjogren’s syndrome model mice. a The pathological map and lymphocyte infiltration rate of the submandibular gland in the short-course group (n = 5). b Pathological map and lymphocyte infiltration rate of submandibular gland lymphocyte infiltration in the long-course group (n = 5)

Back to article page